Home Health & Fitness Researchers to explore anti-TNF drug to treat Covid-19 patients at care homes

Researchers to explore anti-TNF drug to treat Covid-19 patients at care homes

Researchers at the University of Oxford are exploring the anti-tumour necrosis factor (anti-TNF) drug adalimumab to treat Covid-19 patients, especially at care homes.For the trial, researchers will enrol around 750 candidates from community care centres across the United Kingdom in October. The AVID-CC trial will be conducted by the Oxford Clinical Trials Research Unit (OCTRU).Researchers stated in their study that people at care homes are largely affected by the virus, many of whom have shown severe symptoms. However, there is no effective treatment yet for those living in community care settings.Recent studies mentioned in the News Medical journal stated that anti-tumour necrosis factor (anti-TNF) drugs for inflammatory bowel disease and inflammatory arthritis lead to lower hospital admission rate. This may not be the case for other anti-inflammatory drugs.Also read: Should we have Covid-19 lockdowns just for the old?Duncan Richards, Professor of Clinical Therapeutics, University of Oxford, wrote in a statement: “The observed potential of anti-TNF drugs has prompted us to conduct a study in patients in community care to see whether treatment with the anti-TNF drug adalimumab reduces the progression to severe or critical disease or death in Covid-19 patients.”“We think that anti-TNF drugs could be an important treatment for Covid-19 and are very grateful for the support of the Covid-19 Therapeutics Accelerator, which will allow us to find out. I would also like to thank Sandoz Ltd for the provision of adalimumab…Subject to the necessary approvals we hope to start recruiting patients in late October,” he added.Professor Adam Gordon, Professor of Care of Older People at the University of Nottingham, and Consultant Geriatrician, said in a statement cited in the News Medical journal: “We have seen lots of examples, earlier in the Covid-19 pandemic, of older people in care homes being disadvantaged regarding access to treatments simply because of where they live.”Also read: This is why Covid-19 could be life-threatening for some patientsHe added: “This study is an exciting opportunity to open up promising treatments to this most vulnerable, and underserved, group of people. It is an important step forward as we investigate how to manage Covid-19, and more generally in terms of bringing research to the frailest older people.”

Read More


Please enter your comment!
Please enter your name here

- Advertisment -

Most Popular

How can I tell the difference between the flu and COVID-19?

Last Updated : Oct 01, 2020 01:54 PM IST | Source: AP Body aches, sore throat, fever, cough, shortness of breath, fatigue and headaches are symptoms shared by the two. How can I tell the difference between the flu and COVID-19?It’s impossible to tell without a test. Influenza and COVID-19 have such similar symptoms, you…

Cardiac arrest common in sick Covid-19 patients

Photo for representational purpose only. iStock New York, October 1 Cardiac arrest is common in critically ill patients with Covid-19 and is associated with poor survival, particularly among patients aged 80 or older, say researchers. The findings, published in the journal The BMJ, could help guide end-of-life care discussions with critically ill patients with Covid-19…

Beware: Vitamin D deficiency can make you obese and lead to stunted growth

Vitamin D, or the ‘Sunshine Vitamin as it is also known as, is one of the essential nutrients that makes your bones and teeth stronger, wards off infections and diseases and keeps you cheerful. This fat-soluble vitamin can also bring down your risk of cancer, autoimmune diseases, heart disease and diabetes. But unfortunately, as many…

COVID-19 cases decline, deaths increase in Chandigarh as September ends

Naina MishraTribune News ServiceChandigarh, October 1 As September comes to an end, the Union Territory has started to witness a decline in the number of positive COVID-19 cases, and daily tests.  However, COVID deaths have increased with every passing week.  September has recorded 100 COVID-19 deaths whereas August reported only 39 deaths.  At least three…

Recent Comments